-transparent.png){kind=logo}
The tertiary structure of a unique C5a receptor antagonist was determined by two-dimensional NMR spectroscopy. The core domain of this 8-kDa antagonist exists as an antiparallel helical bundle, similar to recombinant human (rh)-C5a. However, unlike C5a, the antagonist's C terminus was found to be conformationally restricted along a groove between helices one and four in the core domain. This conformational restriction situates C-terminal D-Arg 75 in a wedge between core residues Arg 46 and His 15. Correlation of the antagonist's tertiary structure with point mutation analysis revealed the formation of a positively charged contiguous contact surface comprised of D-Arg 75, Arg 46, Lys 49, and His 15. The significance of this surface in generating antagonist properties implies a single binding site with the C5a receptor and provides a structural template for drug design.
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
June 2013,
Protein expression and purification,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
January 2018,
Nature,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
January 2005,
Anticancer research,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
September 2003,
Annals of the New York Academy of Sciences,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
July 1994,
FEBS letters,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
February 1999,
British journal of pharmacology,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
October 1992,
Journal of protein chemistry,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
December 2006,
Current opinion in molecular therapeutics,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
June 1985,
The Journal of biological chemistry,
X Zhang, and
W Boyar, and
N Galakatos, and
N C Gonnella
November 2001,
Biochemistry,
